|
RYK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70193999999846E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.983630E-04 |
| Normal-vs-Stage2 |
2.211000E-04 |
| Normal-vs-Stage3 |
4.7311999999966E-06 |
| Normal-vs-Stage4 |
3.52839999999688E-05 |
| Stage1-vs-Stage2 |
1.882160E-01 |
| Stage1-vs-Stage3 |
8.914200E-02 |
| Stage1-vs-Stage4 |
1.749820E-01 |
| Stage2-vs-Stage3 |
7.570200E-01 |
| Stage2-vs-Stage4 |
7.164800E-01 |
| Stage3-vs-Stage4 |
9.191800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60349999999143E-05 |
| Normal-vs-AfricanAmerican |
4.039700E-04 |
| Normal-vs-Asian |
3.726000E-01 |
| Caucasian-vs-AfricanAmerican |
9.264800E-01 |
| Caucasian-vs-Asian |
4.006600E-01 |
| AfricanAmerican-vs-Asian |
4.116000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.80460000463046E-08 |
| Normal-vs-Female |
3.231000E-04 |
| Male-vs-Female |
6.151600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.197900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.57650000000209E-05 |
| Normal-vs-Age(61-80Yrs) |
1.53746999999038E-05 |
| Normal-vs-Age(81-100Yrs) |
6.43679999999813E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.730800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.859200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.740300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.711200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.424300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.734300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.109000E-01 |
| Normal-vs-Grade 2 |
7.611300E-04 |
| Normal-vs-Grade 3 |
1.60469999954671E-07 |
| Normal-vs-Grade 4 |
4.22119999998749E-06 |
| Grade 1-vs-Grade 2 |
1.217840E-01 |
| Grade 1-vs-Grade 3 |
5.999900E-04 |
| Grade 1-vs-Grade 4 |
7.698700E-03 |
| Grade 2-vs-Grade 3 |
3.954000E-04 |
| Grade 2-vs-Grade 4 |
1.727900E-02 |
| Grade 3-vs-Grade 4 |
9.228800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.838400E-04 |
| Normal-vs-ccB subtype |
3.78320000000709E-05 |
| ccA subtype-vs-ccB subtype |
3.943400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84299999997462E-06 |
| Normal-vs-N1 |
3.382200E-02 |
| N0-vs-N1 |
9.138800E-01 |
|
|
